Tartu Ülikooli Kliinikum on Tartu Ülikooli kliinikuid ühendav sihtasutus Tartus. See on tervishoiuasutus ja ühtlasi meditsiinihariduse õppebaas. Kliinikumi suurim kliinikuid koondav haiglakompleks asub Tartus Maarjamõisas.

During the past decade, Tartu University Hospital conducted 89 clinical trials. In the 10-year time frame, 89 clinical trials started and 35 clinical trials were completed, i.e. on average, 39.3% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 28 clinical trials were completed. i.e. 65.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tartu University Hospital" #1 sponsor was "Tartu University Hospital" with 10 trials, followed by "University of Tartu" with 10 trials sponsored, "Hoffmann-La Roche" with 8 trials sponsored, "Amgen" with 7 trials sponsored and "Abbott Medical Devices" with 7 trials sponsored. Other sponsors include 76 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tartu University Hospital" #1 collaborator was "Tartu University Hospital" with 7 trials as a collaborator, "North Estonia Medical Centre" with 3 trials as a collaborator, "Estonian Science Foundation" with 2 trials as a collaborator, "Helsinki University Central Hospital" with 2 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include 67 different institutions and companies that were collaborators in the rest 73 trials.

According to Clinical.Site data, the most researched conditions in "Tartu University Hospital" are "Ulcerative Colitis" (5 trials), "Multiple Sclerosis" (4 trials), "Atrial Fibrillation" (3 trials), "Colitis, Ulcerative" (3 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Tartu University Hospital" in a lesser frequency.

Most popular intervention types in "Tartu University Hospital" are "Drug" (81 trials), "Other" (17 trials), "Biological" (11 trials), "Device" (9 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Etrolizumab" (4 trials), "Ocrelizumab" (4 trials), "Adalimumab" (3 trials) and "No intervention" (3 trials). Other intervention names were less common.

The vast majority of trials in "Tartu University Hospital" are 112 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Tartu University Hospital". undefined are not yet recruiting, 26 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in Tartu University Hospital, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Tartu University Hospital, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 15 trials that are defined as “Not Applicable".